The Italian study showed that patients with HCC resulting from viral infections or fatty liver had significantly higher ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Strategic insight into the Liver Cancer Treatment Market reveals a high-growth opportunity, especially in Asia-Pacific, driven by a rising patient po ...

Industry Giants Gilead Sciences, Bristol Myers Squibb, AbbVie, and Merck & Co. Lead the CompetitionDublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Liver Disease Treatments Market" report has been added ...

Among patients with hepatocellular carcinoma, MAFLD was not an independent predictor for overall survival or progression-free ...

Prevalence and risk factors Hepatocellular carcinoma (HCC), the most common ... to HCC,” observed Dr Balraj. > Non-alcoholic fatty liver ­disease (NAFLD): The rise in obesity and diabetes ...

To advance the understanding and treatment of liver disease by pursuing innovative, transformative basic and translational ...

Ahead of Parents' Day, a 54-year-old son presented a healthy new life to a 75-year-old mother through liver transplantation.

Learn more about whether Alnylam Pharmaceuticals, Inc. or Exact Sciences Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.